CAG
GILD icon

Csenge Advisory Group’s Gilead Sciences GILD Stock Holding History

Csenge Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Sell
18,102
-4,015
-18% -$562K 0.12% 159
2025
Q4 		$2.71M Buy
22,117
+723
+3% +$87.9K 0.12% 152
2025
Q3 		$2.37M Buy
21,394
+16,288
+319% +$1.85M 0.11% 158
2025
Q2 		$562K Buy
+5,106
New +$543K 0.03% 398
2025
Q1 		– Sell
-2,442
Closed -$226K – 692
2024
Q4 		$226K Sell
2,442
-3,197
-57% -$288K 0.01% 629
2024
Q3 		$479K Sell
5,639
-1,504
-21% -$115K 0.03% 433
2024
Q2 		$490K Sell
7,143
-1,288
-15% -$86K 0.03% 407
2024
Q1 		$618K Sell
8,431
-5,932
-41% -$456K 0.03% 380
2023
Q4 		$1.16M Buy
14,363
+547
+4% +$42.6K 0.07% 210
2023
Q3 		$1.04M Buy
13,816
+1,219
+10% +$93.8K 0.07% 205
2023
Q2 		$971K Buy
12,597
+1,674
+15% +$134K 0.07% 217
2023
Q1 		$906K Buy
10,923
+379
+4% +$31.4K 0.07% 226
2022
Q4 		$905K Buy
10,544
+1,575
+18% +$125K 0.07% 228
2022
Q3 		$553K Sell
8,969
-574
-6% -$36.2K 0.05% 313
2022
Q2 		$590K Buy
9,543
+4,032
+73% +$250K 0.05% 311
2022
Q1 		$328K Buy
+5,511
New +$352K 0.03% 480
2018
Q4 		– Sell
-216
Closed -$15K – 680
2018
Q3 		$15K Buy
+216
New +$16.3K 0.01% 419

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Csenge Advisory Group's GILD Position: Q1 2026 in Review

Csenge Advisory Group reduced its Gilead Sciences (GILD) stake by 18% in Q1 2026, selling an estimated $562K and leaving 18,102 shares worth $2.52M. The position accounts for 0.12% of the portfolio, ranked #159.

Csenge Advisory Group first reported a position in GILD in Q3 2018 and has held it in 17 quarters since. The position peaked at $2.71M in Q4 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Csenge Advisory Group held 18,102 shares of Gilead Sciences worth $2.52M as of Q1 2026.
  • Csenge Advisory Group sold 4,015 Gilead Sciences shares in Q1 2026, an estimated $562K.
  • Gilead Sciences made up 0.12% of Csenge Advisory Group's portfolio in Q1 2026, its #159 holding.
  • Csenge Advisory Group first reported a position in Gilead Sciences in Q3 2018 and has held it in 17 quarters since.
  • Csenge Advisory Group's Gilead Sciences position peaked at $2.71M in Q4 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.